opendata.bot
Company number
09389592

NEWCELLS BIOTECH LIMITED

Bankruptcy
✓ Status: In Administration. Next accounts due 31 October 2026.

Company details

North West, England Contains OS data © Crown copyright and database right. Contains Royal Mail data © Royal Mail copyright and database right. Source: Office for National Statistics licensed under the Open Government Licence v.3.0.
Registered name
NEWCELLS BIOTECH LIMITED
Company number
09389592
Registered office
11TH FLOOR LANDMARK ST PETER'S SQUARE, 1 OXFORD STREET, MANCHESTER, M1 4PB · 600 other companies at this postcode
Company type
Private Limited Company
Incorporated on
15 January 2015
Status
Bankruptcy
Age
11 years
Nature of business (SIC)
72110 — Research and experimental development on biotechnology
Accounts — next due
31 Oct 2026
Accounts — last made up to
31 Jan 2025
Confirmation statement — next due
29 Jan 2027
Confirmation statement — last
15 Jan 2026

What the register says

Facts from the register, with the dates they are filed under. Not a score: what they mean is for you to judge, and every line can be checked against Companies House itself.

Companies House register snapshot, read 02/09/2026.

People with significant control

Beneficial owners holding over 25% of shares, voting rights or the right to appoint directors

Mercia Fund Management Limited
has significant influence or control
Notified 20/06/2018
North East Accelerator General Partner Limited
has significant influence or control
Notified 06/04/2016
Northstar Ventures Limited
has significant influence or control
Notified 06/04/2016
Nvm Private Equity Llp
has significant influence or control
Notified 20/06/2018
Professor Lyle Armstrong
owns 25–50% of shares
Notified 06/04/2016

Corporate structure

Who controls this company, and who they control in turn

5 controllers Drag to move · scroll to zoom · double-click to expand
Company Person Current control Ended

Connections

Corporate owner has significant influence or control Notified 20/06/2018 Controls 37 companies
North East Accelerator General Partner Limited
has significant influence or control Notified 06/04/2016 Controls 8 companies
Corporate owner has significant influence or control Notified 06/04/2016 Controls 40 companies
Corporate owner has significant influence or control Control ended 20/06/2018 Controls 53 companies
Professor Lyle Armstrong
born 04/1965 · United Kingdom owns 25–50% of shares Control ended 20/06/2018 Controls 2 companies

Change history

Reconstructed from the dated records Companies House publishes

DateChangeWasNow
20/06/2018 Person with significant control ceased Professor Lyle Armstrong
20/06/2018 Person with significant control ceased Nvm Private Equity Llp
20/06/2018 Person with significant control added Nvm Private Equity Llp
20/06/2018 Person with significant control added Mercia Fund Management Limited
06/04/2016 Person with significant control added Professor Lyle Armstrong
06/04/2016 Person with significant control added Northstar Ventures Limited
06/04/2016 Person with significant control added North East Accelerator General Partner Limited

Documents for NEWCELLS BIOTECH LIMITED

Need this one company on file? Buy the document on its own — no plan required.

Company extract£1.99

The full registration record as held today — name, number, status, registered office, company type, previous names, officers, PSC and SIC codes, timestamped for your file.

PDF Order
Financial statements£3.99

Every figure the company’s own accounts state, across each filed period, with year-on-year movement. Most UK companies file small or micro-entity accounts — a balance sheet and a headcount, no turnover or profit.

PDF + CSV Order
Ownership report£3.99

Who controls the company: persons with significant control, the nature of that control, the ownership graph and every other company those controllers hold.

PDF Order

Data protection register

No entry found on the ICO register of fee payers under this name.

Not every organisation has to register — some are exempt. An absent entry is a question to ask, not a finding.

Get this company via API

Every field on this page is available as structured JSON behind one endpoint and one API key.

GET /v1/company/gb/09389592
X-Api-Key: $OPENDATA_KEY
Read the API docs

Frequently asked questions

What is the company number of NEWCELLS BIOTECH LIMITED?
According to the official registry, the company number of NEWCELLS BIOTECH LIMITED is 09389592.
Where is NEWCELLS BIOTECH LIMITED registered?
The registered office is 11TH FLOOR LANDMARK ST PETER'S SQUARE, 1 OXFORD STREET, MANCHESTER, M1 4PB.
What is the SIC code of NEWCELLS BIOTECH LIMITED?
The nature of business is recorded under SIC code 72110 — Research and experimental development on biotechnology.
Who controls NEWCELLS BIOTECH LIMITED?
Mercia Fund Management Limited is recorded as a person with significant control, and has significant influence or control.
When are the next accounts of NEWCELLS BIOTECH LIMITED due?
The next annual accounts are due by 31 October 2026, and the last accounts were made up to 31 January 2025.

About NEWCELLS BIOTECH LIMITED (09389592)

NEWCELLS BIOTECH LIMITED is a private limited company incorporated on 15 January 2015 and registered in the United Kingdom under company number 09389592. Its registered office is at 11TH FLOOR LANDMARK ST PETER'S SQUARE, 1 OXFORD STREET, MANCHESTER, M1 4PB. The recorded nature of business is research and experimental development on biotechnology (SIC 72110). The company is currently bankruptcy , with statutory accounts last made up to 31 January 2025. , and the person with significant control is Mercia Fund Management Limited. This profile is provided by opendata.bot by Noetikos, aggregating official data from Companies House bulk data , last refreshed 2 September 2026.

Companies at the same registered office

Research and experimental development on biotechnology across UK registers

The same sector and the same company, seen through every register we hold

Explore by sector

Every UK company records what it does as a SIC code — browse the sectors around this one.